Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization.
Saved in:
| Title: | Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization. |
|---|---|
| Authors: | Zhang F; Department of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University , Shanghai, People's Republic of China., Yang J; Department of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University , Shanghai, People's Republic of China., Li H; Department of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University , Shanghai, People's Republic of China., Liu M; Department of Nephrology, General Hospital of Jinan Military Command , Jinan, People's Republic of China., Zhang J; Nursing Department, PLA General Hospital, PLA School of Medicine , Beijing, People's Republic of China., Zhao L; Medical Department, General Hospital of Jinan Military Command , Jinan, China., Wang L; Department of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University , Shanghai, People's Republic of China., LingHu R; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Feng F; Department of Pharmacy, General Hospital of Shenyang Military Command , Shenyang, People's Republic of China., Gao X; Department of Gastroenterology, PLA 302 Hospital , Beijing, People's Republic of China., Dong B; Department of Physics, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education) , and Key Laboratory of Surface Physics, Fudan University , Shanghai, People's Republic of China., Liu X; Department of Physics, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education) , and Key Laboratory of Surface Physics, Fudan University , Shanghai, People's Republic of China., Zi J; Department of Physics, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education) , and Key Laboratory of Surface Physics, Fudan University , Shanghai, People's Republic of China., Zhang W; Department of Lymphoma, Affiliated Hospital of Academy of Military Medical Science , Beijing, People's Republic of China., Hu Y; Department of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University , Shanghai, People's Republic of China., Pan J; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Tian L; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Hu Y; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Han Z; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Zhang H; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Wang X; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric , Beijing, People's Republic of China., Zhao L; Department of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of China; National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of China. |
| Source: | Oncoimmunology [Oncoimmunology] 2016 Feb 18; Vol. 5 (5), pp. e1143995. Date of Electronic Publication: 2016 Feb 18 (Print Publication: 2016). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
